Exelixis Announces Second Quarter and Year to Date 2016 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Exelixis Announces Second Quarter and Year to Date 2016 Financial Results and Provides Corporate Update

Exelixis (EXEL) PT Bumped to $8 at Piper Jaffray, Remains Sidelined

August 4, 2016 7:21 AM EDT

Piper Jaffray analyst Edward Tenthoff raised his price target on Exelixis (NASDAQ: EXEL) to $8.00 (from $5.00) but maintained a Neutral rating following results.

Tenthoff commented, "Exelixis reported COMETRIQ sales of $14M in 2Q:16 and CABOMETYX renal cell carcinoma (RCC) sales of $17.6M including... More

Exelixis (EXEL) Tops Q2 EPS by 11c, Revenue Tops Views

August 3, 2016 4:43 PM EDT

Exelixis (NASDAQ: EXEL) reported Q2 EPS of ($0.16), $0.11 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $36.3 million versus the consensus estimate of $17.96 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

... More